Elevated TLR4 Protein Correlates With Better Survival in Lymphocyte-Rich Triple-Negative Tumors
Elevated Toll-like receptor 4 protein levels in triple-negative breast cancer correlate with improved patient survival specifically within lymphocyte-rich tumors.




















